These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8937464)

  • 1. Mechanism-based inhibition of mouse P4502b-10 by selected arylalkynes.
    Beebe LE; Roberts ES; Fornwald LW; Hollenberg PF; Alworth WL
    Biochem Pharmacol; 1996 Nov; 52(10):1507-13. PubMed ID: 8937464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of cytochrome P450.
    Alworth WL; Young-Sciame R; Hecht SS
    Carcinogenesis; 1993 Aug; 14(8):1711-3. PubMed ID: 8353857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes.
    Menicagli S; Lippi A; Criscuoli M; Gervasi PG
    Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver.
    Arinç E; Bozcaarmutlu A
    J Biochem Mol Toxicol; 2003; 17(3):169-76. PubMed ID: 12815613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suicide inhibitors of cytochrome P450 1A1 and P450 2B1.
    Hopkins NE; Foroozesh MK; Alworth WL
    Biochem Pharmacol; 1992 Aug; 44(4):787-96. PubMed ID: 1510726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse.
    Nerurkar PV; Park SS; Thomas PE; Nims RW; Lubet RA
    Biochem Pharmacol; 1993 Sep; 46(5):933-43. PubMed ID: 8373445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition and inactivation of constitutive cytochromes P450 in rat liver by parathion.
    Butler AM; Murray M
    Mol Pharmacol; 1993 Jun; 43(6):902-8. PubMed ID: 8316222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene.
    Roberts ES; Hopkins NE; Zaluzec EJ; Gage DA; Alworth WL; Hollenberg PF
    Arch Biochem Biophys; 1995 Nov; 323(2):295-302. PubMed ID: 7487091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
    Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
    Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.
    Roberts ES; Hopkins NE; Foroozesh M; Alworth WL; Halpert JR; Hollenberg PF
    Drug Metab Dispos; 1997 Nov; 25(11):1242-8. PubMed ID: 9351899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenytoin induction of cytochrome P4502B in mice: effects on hexobarbital hydroxylase activity.
    Kim ND; Yoo JK; Won SM; Park SS; Gelboin HV
    Xenobiotica; 1993 Mar; 23(3):217-25. PubMed ID: 8498085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
    Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
    Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C11 and CYP2B1 are major cytochrome P450 forms involved in styrene oxidation in liver and lung microsomes from untreated rats, respectively.
    Nakajima T; Wang RS; Elovaara E; Gonzalez FJ; Gelboin HV; Vainio H; Aoyama T
    Biochem Pharmacol; 1994 Aug; 48(4):637-42. PubMed ID: 8080435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic selectivity and mechanism-based inactivation of stably expressed and hepatic cytochromes P450 2B4 and 2B5: implications of the cytochrome P450 2B5 polymorphism.
    Grimm SW; Dyroff MC; Philpot RM; Halpert JR
    Mol Pharmacol; 1994 Dec; 46(6):1090-9. PubMed ID: 7808429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperine effects on the expression of P4502E1, P4502B and P4501A in rat.
    Kang MH; Won SM; Park SS; Kim SG; Novak RF; Kim ND
    Xenobiotica; 1994 Dec; 24(12):1195-204. PubMed ID: 7771106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the effects of tebufelone on hepatic cytochromes P450 in the beagle dog.
    Smith BJ; Zupan LA; Hu JK; Diters RW; Gibson GW; Norton JN
    Drug Metab Dispos; 1996 May; 24(5):523-8. PubMed ID: 8723731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
    Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.